Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 23 Jun 2026 for Anika Therapeutics, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Stephen Richard: trading record in brief
Stephen Richard, listed as board member, appears in our data through filings on Anika Therapeutics, Inc. shares, published by SEC (Form 4). In total, 7 filings cover trades dated from 3 September 2020 to 18 June 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 23 June 2026: a share grant, in Anika Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Stephen Richard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
10,402 sharesCommon StockSEC:0001193125-26-279541:0
14,164 shares0Common StockSEC:0001171843-25-004071:0
5,771 shares0Common StockSEC:0001171843-24-003909:0
6,500 shares0Common StockSEC:0001171843-23-003961:0
7,954 shares0Common StockSEC:0001171843-22-004301:0
4,172 shares0Common StockSEC:0001171843-21-004429:0
6 of 6 declarations
